Impact of Sugammadex vs. Neostigmine Reversal on Post-Operative Recovery and Complications
Clinical trial NCT03679611 · COMPLETED
Trial details
- NCT number
- NCT03679611
- Sponsor
- University Health Network, Toronto
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-14
- Primary completion
- 2021-10-26
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.